SEC Company Response from CRESCENT BIOPHARMA, INC. (CBIO) (CIK 0001253689) (CBIO) — Oct 5, 2017
CRESCENT BIOPHARMA, INC. (CBIO) (CIK 0001253689)
Date: Oct. 5, 2017 · CIK: 0001253689 · Accession: 0001104659-17-061140
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-220697
Letter
VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Acceleration Request Requested Date: Friday, October 6, 2017 Requested Time: 4:00 p.m. Eastern Time
Re: GlycoMimetics, Inc. (the “Registrant”) Registration Statement on Form S-3, File No. 333-220697
Dear Mr. Edwards:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-220697) (the “Registration Statement”) to become effective on Friday, October 6, 2017, at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable, or at such later time as the Registrant may orally request via telephone call to the staff (the “Staff”).
Once the Registration Statement has been declared effective, please orally confirm that event with Katie Kazem of Cooley LLP, counsel to the Registrant, at (703) 456-8043, or in her absence, Mark Ballantyne at (703) 456-8084.
Very truly yours,
GLYCOMIMETICS, INC.
Show Raw Text
CORRESP 1 filename1.htm October 5, 2017 VIA EDGAR Mr. Christopher Edwards Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Re: GlycoMimetics, Inc. (the “Registrant”) Registration Statement on Form S-3, File No. 333-220697 Acceleration Request Requested Date: Friday, October 6, 2017 Requested Time: 4:00 p.m. Eastern Time Dear Mr. Edwards: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-220697) (the “Registration Statement”) to become effective on Friday, October 6, 2017, at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable, or at such later time as the Registrant may orally request via telephone call to the staff (the “Staff”). Once the Registration Statement has been declared effective, please orally confirm that event with Katie Kazem of Cooley LLP, counsel to the Registrant, at (703) 456-8043, or in her absence, Mark Ballantyne at (703) 456-8084. Very truly yours, GLYCOMIMETICS, INC. By: /s/ Brian M. Hahn Brian M. Hahn Chief Financial Officer cc: Brent B. Siler, Cooley LLP Brian F. Leaf, Cooley LLP